News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Macdonald R. Loch
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/18/2023 |
4
| Macdonald R. Loch (Chief Medical Officer) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 60,000 options to buy
@ $2.64, valued at
$158.4k
|
|
| 05/26/2023 |
3
| Macdonald R. Loch (Chief Medical Officer) has filed a Form 3 on Acasti Pharma Inc. |
| 03/18/2019 |
4
| Macdonald R. Loch (Director) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Exercised 10,000 restricted stock units
@ $0 |
|
| 08/15/2018 |
4
| Macdonald R. Loch (Director) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Granted 10,000 restricted stock units
@ $0 |
|
| 06/20/2018 |
4
| Macdonald R. Loch (Director) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.1, valued at
$22k
|
|
| 03/22/2018 |
4
| Macdonald R. Loch (Chief Scientific Officer) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $16.41, valued at
$41k
|
|
| 03/21/2018 |
4
| Macdonald R. Loch (Chief Scientific Officer) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $16.66, valued at
$41.7k
Sold 5,000 shares
@ $16.47, valued at
$82.4k
Sold 2,500 shares
@ $16.52, valued at
$41.3k
|
|
| 02/22/2018 |
4
| Macdonald R. Loch (Chief Scientific Officer) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $13.75, valued at
$68.8k
Sold 5,000 shares
@ $13.82, valued at
$69.1k
Sold 2,500 shares
@ $14.49, valued at
$36.2k
|
|
| 03/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|